Cargando…
Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study
BACKGROUND: Genetic testing has become an integrated part of health care for patients with breast or ovarian cancer, and the increasing demand for genetic testing is accompanied by an increasing need for easy access to reliable genetic information for patients. Therefore, we developed a chatbot app...
Autores principales: | Siglen, Elen, Vetti, Hildegunn Høberg, Augestad, Mirjam, Steen, Vidar M, Lunde, Åshild, Bjorvatn, Cathrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504626/ https://www.ncbi.nlm.nih.gov/pubmed/37656502 http://dx.doi.org/10.2196/46571 |
Ejemplares similares
-
Identifying Needs: a Qualitative Study of women’s Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study
por: Augestad, Mirjam Tonheim, et al.
Publicado: (2016) -
Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer
por: Listøl, Wenche, et al.
Publicado: (2017) -
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
por: Høberg-Vetti, Hildegunn, et al.
Publicado: (2016) -
BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories
por: Hovland, Henrikke N., et al.
Publicado: (2022) -
The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23—a likely pathogenic variant with reduced penetrance?
por: Høberg-Vetti, Hildegunn, et al.
Publicado: (2020)